Skip to Content


In the US, Eslicarbazepine (eslicarbazepine systemic) is a member of the drug class dibenzazepine anticonvulsants and is used to treat Epilepsy and Seizures.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiepileptic agent (adjunct)

Chemical Name

(10S)-10-hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepin-5-carboxamide (WHO)

Foreign Names

  • Eslicarbazepinum (Latin)
  • Eslicarbazepin (German)
  • EslicarbazĂ©pine (French)
  • Eslicarbazepina (Spanish)

Generic Names

  • Eslicarbazepine (OS: BAN, USAN)
  • BIA-2-194 (IS)
  • UNII-S5VXA428R4 (IS)
  • Eslicarbazepine Acetate (OS: BANM, USAN)
  • BIA 2-093 (IS)
  • SEP-0002093 (IS)

Brand Names

  • Neurotem
    Temis Lostalo, Argentina
  • Zebinix
    Bial Portela & CA, Serbia; Bial-Portela, Cyprus
  • Aptiom
    Sunovion, United States; Sunovion Pharmaceuticals, Canada
  • Eslicarbazepine G.L.
    G.L. Pharma GmbH, United Kingdom
  • Exalief
    Bial - Portela & C, Lithuania
  • Zebinix
    Bial, Czech Republic; Bial, Portugal; Bial, Romania; Bial - Portela, Slovenia; Bial - Portela & C, Lithuania; Bial - Portela & C. S.A, Iceland; Bial - Portela & Ca, Poland; Bial - Portela & CÂȘ, Estonia; Bial Portela, Greece; Bial-Industrial Farmaceutica, Spain; Eisai, Denmark; Eisai, Finland; Eisai, France; Eisai, United Kingdom; Eisai, Ireland; Eisai, Netherlands; Eisai, Norway; Eisai, Sweden; Eisai, Slovakia; Orifarm, Norway
  • Zebinix 800mg
    Abacus, Austria; Bial Portela, Austria; Eisai, Germany; Emra-Med Arzneimittel, Austria; Haemato Pharm, Austria


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.